Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy.

Balbi M, Donadon V, Ghersetti M, Grazioli S, Valentina GD, Gardenal R, Mas MD, Casarin P, Zanette G, Miranda C, Cimarosti P.

Int J Environ Res Public Health. 2010 Apr;7(4):1366-78. doi: 10.3390/ijerph7041366. Epub 2010 Mar 29.

2.

Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma.

Donadon V, Balbi M, Valent F, Avogaro A.

World J Gastroenterol. 2010 Jun 28;16(24):3025-32.

3.

Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.

Donadon V, Balbi M, Mas MD, Casarin P, Zanette G.

Liver Int. 2010 May;30(5):750-8. doi: 10.1111/j.1478-3231.2010.02223.x. Epub 2010 Mar 12.

PMID:
20331505
4.

Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitus.

Donadon V, Balbi M, Zanette G.

Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):465-7. doi: 10.1586/egh.09.41. No abstract available.

PMID:
19817667
5.

Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.

Donadon V, Balbi M, Ghersetti M, Grazioli S, Perciaccante A, Della Valentina G, Gardenal R, Dal Mas M, Casarin P, Zanette G, Miranda C.

World J Gastroenterol. 2009 May 28;15(20):2506-11.

6.

Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.

Donadon V, Balbi M, Casarin P, Vario A, Alberti A.

World J Gastroenterol. 2008 Oct 7;14(37):5695-700.

Supplemental Content

Loading ...
Support Center